In vitro and in vivo genotoxicity investigations of differently sized amorphous SiO2 nanomaterials.
暂无分享,去创建一个
M. Wiemann | A. Hartwig | M. Schulz | W. Wohlleben | L. Ma-Hock | R. Landsiedel | U. Sauer | E. Maser
[1] Reinhard Kreiling,et al. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). , 2015, Regulatory toxicology and pharmacology : RTP.
[2] Henriqueta Louro,et al. Genotoxicity of synthetic amorphous silica nanoparticles in rats following short‐term exposure. Part 1: Oral route , 2015, Environmental and molecular mutagenesis.
[3] V. Fessard,et al. Genotoxicity of synthetic amorphous silica nanoparticles in rats following short‐term exposure, part 2: Intratracheal instillation and intravenous injection , 2015, Environmental and molecular mutagenesis.
[4] Robert Landsiedel,et al. Influence of dispersive agent on nanomaterial agglomeration and implications for biological effects in vivo or in vitro. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.
[5] Jürgen Schnekenburger,et al. Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. , 2014, Nanomedicine.
[6] Robert Landsiedel,et al. Concern-Driven Safety Assessment of Nanomaterials: An Integrated Approach Using Material Properties, Hazard, Biokinetic, and Exposure Data and Considerations on Grouping and Read-Across , 2014 .
[7] M. Voetz,et al. As-Produced: Intrinsic Physico-Chemical Properties and Appropriate Characterization Tools , 2014 .
[8] F. Alessandrini,et al. Toxicological effects of metal oxide nanomaterials , 2014 .
[9] M. Kirsch‐Volders,et al. Co-assessment of cell cycle and micronucleus frequencies demonstrates the influence of serum on the in vitro genotoxic response to amorphous monodisperse silica nanoparticles of varying sizes , 2014, Nanotoxicology.
[10] N. Konduru,et al. Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium , 2014 .
[11] Reinhard Kreiling,et al. A critical appraisal of existing concepts for the grouping of nanomaterials. , 2014, Regulatory toxicology and pharmacology : RTP.
[12] C. Scoglio,et al. Nanoparticle surface characterization and clustering through concentration-dependent surface adsorption modeling. , 2014, ACS nano.
[13] Maria Dusinska,et al. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles , 2014, Nanotoxicology.
[14] M. Wiemann,et al. Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials , 2014, Particle and Fibre Toxicology.
[15] Robert Landsiedel,et al. Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. , 2014, Toxicology and applied pharmacology.
[16] Philip Demokritou,et al. Estimating the effective density of engineered nanomaterials for in vitro dosimetry , 2014, Nature Communications.
[17] Barbara Witt,et al. Cytotoxicity and genotoxicity of nano - and microparticulate copper oxide: role of solubility and intracellular bioavailability , 2014, Particle and Fibre Toxicology.
[18] P. Magusin,et al. Nucleation and growth of monodisperse silica nanoparticles. , 2014, Nano letters.
[19] Maria João Silva,et al. Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.
[20] A. Elder,et al. Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation , 2014, Particle and Fibre Toxicology.
[21] Craig A. Poland,et al. Nanotoxicity: challenging the myth of nano-specific toxicity. , 2013, Current opinion in biotechnology.
[22] D. Lison,et al. In search of the chemical basis of the hemolytic potential of silicas. , 2013, Chemical research in toxicology.
[23] Hugh J. Byrne,et al. Concern-driven integrated approaches to nanomaterial testing and assessment – report of the NanoSafety Cluster Working Group 10 , 2013, Nanotoxicology.
[24] Robert Landsiedel,et al. Genotoxicity of nanomaterials: Refining strategies and tests for hazard identification , 2013, Environmental and molecular mutagenesis.
[25] B. Onida,et al. Genotoxicity of amorphous silica particles with different structure and dimension in human and murine cell lines. , 2013, Mutagenesis.
[26] Dong‐Wan Kim,et al. Comparison of toxicity between the different-type TiO2 nanowires in vivo and in vitro , 2013, Archives of Toxicology.
[27] Heinrich Ernst,et al. Evaluation of immunohistochemical markers to detect the genotoxic mode of action of fine and ultrafine dusts in rat lungs. , 2013, Toxicology.
[28] P. Morfeld,et al. Deposition behavior of inhaled nanostructured TiO2 in rats: fractions of particle diameter below 100 nm (nanoscale) and the slicing bias of transmission electron microscopy , 2012, Inhalation toxicology.
[29] Wendel Wohlleben,et al. Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas , 2012, Journal of Nanoparticle Research.
[30] K. Turteltaub,et al. Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry. , 2012, Nano letters.
[31] Y. Yoshioka,et al. Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells. , 2012, Biochemical and biophysical research communications.
[32] M. Morille,et al. Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. , 2012, Toxicology.
[33] N. Hondow,et al. Mechanism of cellular uptake of genotoxic silica nanoparticles , 2012, Particle and Fibre Toxicology.
[34] A. T. Saber,et al. Inflammatory and genotoxic effects of nanoparticles designed for inclusion in paints and lacquers , 2012, Nanotoxicology.
[35] G. Giudetti,et al. Mechanisms of toxicity induced by SiO2 nanoparticles of in vitro human alveolar barrier: effects on cytokine production, oxidative stress induction, surfactant proteins A mRNA expression and nanoparticles uptake , 2012, Nanotoxicology.
[36] H. Karlsson,et al. DNA damage induced by micro- and nanoparticles--interaction with FPG influences the detection of DNA oxidation in the comet assay. , 2012, Mutagenesis.
[37] Maria Dusinska,et al. Can Standard Genotoxicity Tests be Applied to Nanoparticles? , 2012, Journal of toxicology and environmental health. Part A.
[38] Robert Landsiedel,et al. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[39] Douglas Gilliland,et al. Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts. , 2012, Mutation research.
[40] Stefan Pfuhler,et al. Silica nanoparticles administered at the maximum tolerated dose induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. , 2012, Mutation research.
[41] B. van Ravenzwaay,et al. Investigation on the genotoxicity of different sizes of gold nanoparticles administered to the lungs of rats. , 2012, Mutation research.
[42] Benoit Nemery,et al. Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: the role of size and surface area. , 2012, Toxicology letters.
[43] J. Godnić-Cvar,et al. Genotoxicity of Metal Nanoparticles: Focus on In Vivo Studies , 2012, Arhiv za higijenu rada i toksikologiju.
[44] Claus-Michael Lehr,et al. Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions. , 2012, ACS nano.
[45] F. Oesch,et al. Toxico-/biokinetics of nanomaterials , 2012, Archives of Toxicology.
[46] H. Bockhorn,et al. Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages , 2012, Nanotoxicology.
[47] C. Klein,et al. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies , 2012, Archives of Toxicology.
[48] Claudia Fruijtier-Pölloth. The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material. , 2012, Toxicology.
[49] S. Słomkowski,et al. Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro , 2012, Nanotoxicology.
[50] Sumit Arora,et al. Nanotoxicology and in vitro studies: the need of the hour. , 2012, Toxicology and applied pharmacology.
[51] W. Wohlleben,et al. Artifacts by marker enzyme adsorption on nanomaterials in cytotoxicity assays with tissue cultures , 2011 .
[52] Wim H de Jong,et al. Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay , 2011, Nanotoxicology.
[53] M. Roller,et al. In vitro genotoxicity data of nanomaterials compared to carcinogenic potency of inorganic substances after inhalational exposure. , 2011, Mutation research.
[54] Dominique Lison,et al. The nanosilica hazard: another variable entity , 2010, Particle and Fibre Toxicology.
[55] Joel G Pounds,et al. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.
[56] M. Kirsch‐Volders,et al. Exploring the aneugenic and clastogenic potential in the nanosize range: A549 human lung carcinoma cells and amorphous monodisperse silica nanoparticles as models , 2010, Nanotoxicology.
[57] David B Warheit,et al. Rationale of genotoxicity testing of nanomaterials: Regulatory requirements and appropriateness of available OECD test guidelines , 2010, Nanotoxicology.
[58] F. Oesch,et al. Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UV-protection in cosmetic formulations , 2010, Nanotoxicology.
[59] Mark Bradley,et al. Metal Oxide Nanoparticles Induce Unique Inflammatory Footprints in the Lung: Important Implications for Nanoparticle Testing , 2010, Environmental health perspectives.
[60] L. Ferguson. Chronic inflammation and mutagenesis. , 2010, Mutation research.
[61] David B Warheit,et al. Changing the dose metric for inhalation toxicity studies: Short-term study in rats with engineered aerosolized amorphous silica nanoparticles , 2010, Inhalation toxicology.
[62] Marianne Geiser,et al. Deposition and biokinetics of inhaled nanoparticles , 2010, Particle and Fibre Toxicology.
[63] Amy K Madl,et al. Health effects of inhaled engineered and incidental nanoparticles , 2009, Critical reviews in toxicology.
[64] Saji George,et al. A predictive toxicological paradigm for the safety assessment of nanomaterials. , 2009, ACS nano.
[65] H. Karlsson,et al. Size-dependent toxicity of metal oxide particles--a comparison between nano- and micrometer size. , 2009, Toxicology letters.
[66] Laetitia Gonzalez,et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. , 2009, Small.
[67] Markus Schulz,et al. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. , 2009, Mutation research.
[68] Chao Liu,et al. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition , 2009, Journal of applied toxicology : JAT.
[69] Iseult Lynch,et al. Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. , 2008, Nano letters.
[70] Takashi Omori,et al. Statistical issues in the use of the comet assay. , 2008, Mutagenesis.
[71] Laetitia Gonzalez,et al. Genotoxicity of engineered nanomaterials: A critical review , 2008 .
[72] J. Arts,et al. Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[73] Joel G Pounds,et al. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[74] Roel P F Schins,et al. Genotoxicity of Poorly Soluble Particles , 2007, Inhalation toxicology.
[75] Vicki Stone,et al. Toxicology of nanoparticles: A historical perspective , 2007 .
[76] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[77] W. MacNee,et al. Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure , 2005, Particle and Fibre Toxicology.
[78] Julie W. Fitzpatrick,et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.
[79] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[80] Dieter Hauschke,et al. Biostatistical Assessment of Mutagenicity Studies by Including the Positive Control , 2005, Biometrical journal. Biometrische Zeitschrift.
[81] David M. Brown,et al. Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[82] Ludwig A Hothorn,et al. Two-stage Testing of Safety: A Statistical View , 2003, Alternatives to laboratory animals : ATLA.
[83] M. O’Reilly,et al. Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[84] B. Brunekreef,et al. IMMUNE BIOMARKERS IN RELATION TO EXPOSURE TO PARTICULATE MATTER: A Cross-Sectional Survey in 17 Cities of Central Europe , 2000, Inhalation toxicology.
[85] Stephen S. Olin,et al. THE RELEVANCE OF THE RAT LUNG RESPONSE TO PARTICLE OVERLOAD FOR HUMAN RISK ASSESSMENT: A Workshop Consensus Report , 2000, Inhalation toxicology.
[86] S. Margulies,et al. Alveolar epithelial surface area-volume relationship in isolated rat lungs. , 1999, Journal of applied physiology.
[87] Munoz-Aguado,et al. Sol-Gel Synthesis of Microporous Amorphous Silica from Purely Inorganic Precursors , 1997, Journal of colloid and interface science.
[88] A. Hartwig,et al. Sensitive analysis of oxidative DNA damage in mammalian cells: use of the bacterial Fpg protein in combination with alkaline unwinding. , 1996, Toxicology letters.
[89] B. Lehnert,et al. Correlation Between Particle Size, in Vivo Particle Persistence, and Lung Injury , 1994 .
[90] D. Warheit,et al. Development of a short-term inhalation bioassay to assess pulmonary toxicity of inhaled particles: comparisons of pulmonary responses to carbonyl iron and silica. , 1991, Toxicology and applied pharmacology.
[91] E. Thompson,et al. A micro-method for measuring total protein in cerebrospinal fluid by using benzethonium chloride in microtiter plate wells. , 1989, Clinical chemistry.
[92] F Romagna,et al. The automated bone marrow micronucleus test. , 1989, Mutation research.
[93] R. Tice,et al. A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.
[94] J. Heddle,et al. Towards an improved micronucleus test: studies on 3 model agents, mitomycin C, cyclophosphamide and dimethylbenzanthracene. , 1980, Mutation research.
[95] O. Nishikaze,et al. New micro-turbidimetric method for determination of protein in cerebrospinal fluid and urine. , 1979, Clinical chemistry.
[96] W Schmid,et al. The micronucleus test. , 1975, Mutation research.
[97] Wendel Wohlleben,et al. Nanospecific Guidance in REACH: A Comparative Physical-Chemical Characterization of 15 Materials with Methodical Correlations , 2013 .
[98] Steffen Foss Hansen,et al. Specific Advice on Fulfilling Information Requirements for Nanomaterials under REACH (RIP-oN 2) – Final Project Report , 2011 .
[99] Steffen Foss Hansen,et al. Specific Advice on Exposure Assessment and Hazard/Risk Characterisation for Nanomaterials under REACH (RIP-oN 3) - Final Project Report , 2011 .
[100] Steffen Foss Hansen,et al. Survey on basic knowledge about exposure and potential environmental and health risks for selected nanomaterials , 2011 .
[101] Peter Wick,et al. The automated FADU-assay, a potential high-throughput in vitro method for early screening of DNA breakage. , 2011, ALTEX.
[102] P. M. Williams,et al. Confounding experimental considerations in nanogenotoxicology. , 2009, Mutagenesis.
[103] S. Doak,et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. , 2009, Biomaterials.
[104] Robert Landsiedel,et al. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. , 2009, Inhalation toxicology.
[105] Martin M. Schumacher,et al. Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations. , 2004, Mutagenesis.
[106] R. Tice,et al. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing , 2000, Environmental and molecular mutagenesis.
[107] D. Warheit,et al. Pulmonary Toxicity Assessments Of Inhaled Ethylene Oxide/Propylene Oxide Copolymer Lubricants In Rats , 1995 .
[108] M. Salamone. Toward an improved micronucleus test. Studies on 3 model agents, mitomycin C, CPA and dimethylbenzan-thracene , 1980 .